Kolexia
Thuret Isabelle Pédiatrie
Thuret Isabelle
Pédiatrie
Hôpital La Timone Enfants
Marseille, France
128 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thalassémie Drépanocytose Bêta-Thalassémie Anémie Surcharge en fer Réaction transfusionnelle Accident vasculaire cérébral Maladie du greffon contre l'hôte Maladies vasculaires

Collaborateurs

Voir plus
Pondarre Corinne
Pondarre Corinne
Centre Hospitalier Intercommunal Créteil, Créteil, France
Bernaudin Francoise
Bernaudin Francoise
Centre Hospitalier Intercommunal Créteil, Créteil, France
Paillard Catherine
Paillard Catherine
Hôpital Hautepierre, Strasbourg, France
Brousse Valentine
Brousse Valentine
Hôpital Robert-Debré, Paris, France

Industries

Voir plus
Bluebird
5 collaboration(s)
Dernière en 2021
Vertex
4 collaboration(s)
Dernière en 2023
Novartis
3 collaboration(s)
Dernière en 2021
Pfizer
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Talasemias en el niño
EMC. Pediatria   01 mars 2024
Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.
Haematologica   22 février 2024
Sustained Efficacy and Safety in Adult and Pediatric Patients with Transfusion-Dependent β-Thalassemia up to 9 Years Post Treatment with Betibeglogene Autotemcel (Beti-cel)
Abstracts from the 2024 Tandem Meetings of ASTCT and CIBMTR, February 21-24, 2024, San Antonio, Texas, USA   01 février 2024
Improvement in Iron Burden in Patients with Transfusion-Dependent β-Thalassemia (TDT) Treated with Betibeglogene Autotemcel (Beti-cel) Gene Therapy: Up to 9 Years of Follow-up
65th ASH Annual Meeting Abstracts   02 novembre 2023
Sustained Efficacy, Safety, and Improved Quality of Life in Adult and Pediatric Patients with Transfusion-Dependent β-Thalassemia up to 9 Years Post Treatment with Betibeglogene Autotemcel (Beti-cel)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC).
Bone marrow transplantation   04 août 2023
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study: ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Essai Clinique (Addmedica)   14 juin 2023
A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype: A Phase 3 Single Arm Study Evaluating the Efficacy and Safety of Gene Therapy in Subjects With Transfusion-dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype, by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a Lentiviral βA-T87Q-Globin Vector in Subjects ≤50 Years of Age
Essai Clinique (Bluebird)   22 mai 2023
β-Thalassemia in childhood: Current state of health in a high-income country.
British journal of haematology   06 janvier 2023
Overview of Sickle-cell disease management in the Pediatric Hematology and Oncology Center of Rabat (Morocco)
Middle East and North Africa Hematology Congress 2023 and 5th HEMNET forum   01 janvier 2023